WWC proteins-mediated compensatory mechanism restricts schwannomatosis driven by NF2 loss of function

Xueying Wang1, Rui Zhu1, Pengcheng Yu1

  • 1Institute of Pediatrics, Children's Hospital of Fudan University, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, State Key Laboratory of Genetic Engineering, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.

Science Advances
|January 22, 2025
PubMed

Insights

Researchers developed a new mouse model for NF2-related schwannomatosis by deleting Nf2 and Wwc1/2 genes. This model enables faster preclinical studies and drug screening for nerve tumors.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • NF2-related schwannomatosis (NF2) is a genetic disorder caused by NF2 gene mutations, leading to nerve tumors.
  • Existing mouse models for NF2 exhibit slow tumor development and low penetrance, hindering preclinical research.
  • NF2 protein normally recruits E3 ubiquitin ligases to degrade WWC1-3, preventing YAP/TAZ hyperactivation.

Purpose of the Study:

  • To develop a more effective preclinical model for NF2-related schwannomatosis.
  • To investigate the role of WWC1-3 accumulation in NF2-mutated cells.
  • To identify potential therapeutic drugs for NF2-related schwannomatosis.

Main Methods:

  • Generated a novel mouse model by concurrently deleting Nf2 and Wwc1/2 genes in Schwann cells.
  • Utilized histological and single-cell transcriptome analysis for model validation.
  • Established a cell line and syngeneic tumor model for drug screening.

Main Results:

  • The new mouse model displays complete penetrance and short latency, closely mimicking human NF2-related schwannomatosis.
  • WWC1-3 accumulation was observed as a compensatory mechanism in NF2-mutated cells.
  • Identified candidate drugs that effectively inhibit schwannoma progression in the developed models.

Conclusions:

  • Developed rapid, transplantable mouse models for NF2-related schwannomatosis research.
  • These models will accelerate basic and translational studies for NF2.
  • Identified potential therapeutic strategies for treating nerve tumors in NF2.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.5K
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
702
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
39.6K